Younger age of escalation of cardiovascular risk factors in Asian Indian subjects by Gupta, Rajeev et al.
BioMed  Central
Page 1 of 12
(page number not for citation purposes)
BMC Cardiovascular Disorders
Open Access Research article
Younger age of escalation of cardiovascular risk factors in Asian 
Indian subjects
Rajeev Gupta*1, Anoop Misra2, Naval K Vikram3, Dimple Kondal3, 
Shaon Sen Gupta3, Aachu Agrawal5 and RM Pandey4
Address: 1Department of Medicine, Fortis Escorts Hospital, Jaipur 302017, India, 2Department of Diabetes and Metabolic Diseases, Fortis Rajan 
Dhall Hospital, New Delhi 110055, India, 3Department of Medicine, All India Institute of Medical Sciences, New Delhi 110029, India, 
4Department of Biostatistics, All India Institute of Medical Sciences, New Delhi 110029, India and 5Department of Home Science, University of 
Rajasthan, Jaipur 302004, India
Email: Rajeev Gupta* - rajeevg@satyam.net.in; Anoop Misra - anoopmisra@gmail.com; Naval K Vikram - navalvikram@gmail.com; 
Dimple Kondal - navalvikram@gmail.com; Shaon Sen Gupta - navalvikram@gmail.com; Aachu Agrawal - aachuagrawal@gmail.com; 
RM Pandey - rmpandey@gmail.com
* Corresponding author    
Abstract
Background: Cardiovascular risk factors start early, track through the young age and manifest in
middle age in most societies. We conducted epidemiological studies to determine prevalence and
age-specific trends in cardiovascular risk factors among adolescent and young urban Asian Indians.
Methods: Population based epidemiological studies to identify cardiovascular risk factors were
performed in North India in 1999–2002. We evaluated major risk factors-smoking or tobacco use,
obesity, truncal obesity, hypertension, dysglycemia and dyslipidemia using pre-specified definitions
in 2051 subjects (male 1009, female 1042) aged 15–39 years of age. Age-stratified analyses were
performed and significance of trends determined using regression analyses for numerical variables
and C2 test for trend for categorical variables. Logistic regression was used to identify univariate
and multivariate odds ratios (OR) for correlation of age and risk factors.
Results: In males and females respectively, smoking or tobacco use was observed in 200 (11.8%)
and 18 (1.4%), overweight or obesity (body mass index, BMI ³ 25 kg/m2) in 12.4% and 14.3%, high
waist-hip ratio, WHR (males > 0.9, females > 0.8) in 15% and 32.3%, hypertension in 5.6% and 3.1%,
high LDL cholesterol (³ 130 mg/dl) in 9.4% and 8.9%, low HDL cholesterol (<40 mg/dl males, <50
mg/dl females) in 16.2% and 49.7%, hypertriglyceridemia (³ 150 mg/dl) in 9.7% and 6%, diabetes in
1.0% and 0.4% and the metabolic syndrome in 3.4% and 3.6%. Significantly increasing trends with
age for indices of obesity (BMI, waist, WHR), glycemia (fasting glucose, metabolic syndrome) and
lipids (cholesterol, LDL cholesterol, HDL cholesterol) were observed (p for trend < 0.01). At age
15–19 years the prevalence (%) of risk factors in males and females, respectively, was overweight/
obesity in 7.6, 8.8; high WHR 4.9, 14.4; hypertension 2.3, 0.3; high LDL cholesterol 2.4, 3.2; high
triglycerides 3.0, 3.2; low HDL cholesterol 8.0, 45.3; high total:HDL ratio 3.7, 4.7, diabetes 0.0 and
metabolic syndrome in 0.0, 0.2 percent. At age groups 20–29 years in males and females, ORs were,
for smoking 5.3, 1.0; obesity 1.6, 0.8; truncal obesity 4.5, 3.1; hypertension 2.6, 4.8; high LDL
cholesterol 6.4, 1.8; high triglycerides 3.7, 0.9; low HDL cholesterol 2.4, 0.8; high total:HDL
cholesterol 1.6, 1.0; diabetes 4.0, 1.0; and metabolic syndrome 37.7, 5.7 (p < 0.05 for some). At age
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30–39, ORs were- smoking 16.0, 6.3; overweight 7.1, 11.3; truncal obesity 21.1, 17.2; hypertension
13.0, 64.0; high LDL cholesterol 27.4, 19.5; high triglycerides 24.2, 10.0; low HDL cholesterol 15.8,
14.1; high total:HDL cholesterol 37.9, 6.10; diabetes 50.7, 17.4; and metabolic syndrome 168.5,
146.2 (p < 0.01 for all parameters). Multivariate adjustment for BMI, waist size and WHR in men
and women aged 30–39 years resulted in attenuation of ORs for hypertension and dyslipidemias.
Conclusion:  Low prevalence of multiple cardiovascular risk factors (smoking, hypertension,
dyslipidemias, diabetes and metabolic syndrome) in adolescents and rapid escalation of these risk
factors by age of 30–39 years is noted in urban Asian Indians. Interventions should focus on these
individuals.
Background
Cardiovascular diseases in developing countries are char-
acterized by early age of onset and greater mortality [1].
Worldwide data reveal that while more than 70% of
deaths in high income countries occur after the age of 70
years, in low and middle income countries more than 70
percent deaths occur below this age [2,3]. Coronary heart
disease occurs at least ten years earlier in South Asians as
compared to other ethnic groups and the average age of
stroke is much lower than in the western countries. The
INTERHEART Study [4] reported that the mean age of
myocardial infarction in South Asians was 52 years as
compared to 60–65 years in European and North Ameri-
can cohorts. This study also reported that usual cardiovas-
cular risk factors important in older subjects were equally
important in the young South Asians [4].
Cardiovascular risk factors have been studied in the
younger populations-children, adolescents, and youth in
different parts of the world [5]. These studies have been
mainly confined to high income countries of North Amer-
ica, Europe and Australasia. Examples from USA include
the Bogalusa Heart Study in Caucasians and Black Ameri-
cans [6], National Health and Nutrition Examination Sur-
veys (NHANES) [7], Muscatine Study [8], Coronary Artery
Risk Development in Young Adults (CARDIA) study [9],
Atherosclerosis Risk in Young Adults (ARYA) study [10],
Atherosclerosis Risk Factors in Male Youngsters (ARMY)
study [11], Pathobiological Determinants of Atheroscle-
rosis in Young (PDAY) study [12], Minneapolis Children's
Blood Pressure Study [13], and in Europe the Cardiovas-
cular Risk in Young Finns study [14], North Ireland Young
Heart Project [15] and many British studies [16]. All these
studies have reported that the atherosclerosis factors start
early in childhood and youth and the risk factors tend to
track and magnify with age. The mean age at which the
risk factors establish varies from 40–50 years [17-19].
Young subjects have not been well studied from low
income countries. In India some studies have reported a
moderate to high prevalence of multiple atherosclerosis
risk factors in the adolescents and the young [20,21].
Studies from metropolitan cities in non-governmental
schools report a high prevalence of obesity [22]. In low-
income schools in Indian urban and rural areas there is a
low prevalence of obesity but high prevalence of smoking
and tobacco use [23]. No studies that systematically eval-
uate these risk factors with age have been performed. Such
studies are essential to develop cost-effective screening
and intervention programs. We performed population
based cross-sectional studies in two North Indian cities to
study cardiovascular risk factors in the young subjects 15
to 39 years of age. The aims of the study were to determine
prevalence of multiple cardiovascular risk factors in the
adolescent and young adults and to study the age-group
where risk factor determinants such as obesity and central
obesity emerge and association of these with prevalence
of high blood pressure, lipid abnormalities, diabetes, and
metabolic syndrome.
Methods
To determine prevalence of various cardiovascular risk
factors in adolescents and young adults, we performed
population-based epidemiological studies in two north
Indian cities, Jaipur and Delhi. The studies were approved
by respective institutional ethics committees. These epide-
miological population based studies were conducted
between 1999 and 2002 in these cities by two investiga-
tors. One study was conducted in New Delhi that
included subjects aged 14–25 years drawn from an
approximate total population of 15,000 subjects from
schools and colleges of southwest Delhi using multistage
cluster sampling based on World Health Organization
(WHO) Expanded Program of Immunization Sampling
Plan as described elsewhere [24]. The data of subjects in
age-group 15–25 years (n = 1680, 865 males, 815
females) were included for present analysis. The second
study was conducted in the city of Jaipur in northwestern
India using previously published methodology [25]. Total
population of Jaipur in more than 23 million and the
study was performed in six localities of Jaipur with popu-
lation of 130,000 and 1123 subjects of the target 1800
(response 62.4%) were evaluated. In the present analysis,
the data of subjects belonging to the age group 20–39
years (n = 371, 194 males, 177 females) were included.
Informed consent was obtained from parents and schoolBMC Cardiovascular Disorders 2009, 9:28 http://www.biomedcentral.com/1471-2261/9/28
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authorities in children £  18 years of age and from all the
adult subjects according to the ethics committee guide-
lines. History of previously diagnosed hypertension, dia-
betes or other diseases and smoking status or tobacco use
in other forms was obtained.
Height, weight, waist and hip circumferences measure-
ments were recorded using previously reported methodol-
ogy at each centre by a single centrally trained observer
[24]. Blood pressure (BP) was recorded using a standard
mercury sphygmomanometer with the subject seated and
rested for five minutes. At least two readings at 5 minute
interval were recorded and in case of an abnormal read-
ing, another reading was obtained after 30 minutes. The
data of anthropometric parameters (height, weight, waist
size, and hip size) and blood pressure measurements were
available for all subjects. Central training for technicians
was performed to achieve uniformity in measurements
and data collection. Height and weight were measured
with calibrated instruments, waist was measured using a
non-stretch steel tape measure at the mid-point of lower
ribs and iliac crest in mid expiration in standing position
and hip circumference was measured at inter-trochanteric
level as reported earlier [24]. Fasting blood sample was
Table 1: Physical and Biochemical Characteristics in the Study Subjects
Variables Males (n = 1009) Females (n = 1042) Overall (n = 2051)
Weight (kg) 57.8 ± 13.2 50.4 ± 10.1* 54.0 ± 12.3
Body mass index (kg/m2) 20.6 ± 4.1 20.7 ± 3.9 20.7 ± 4.0
Obesity (BMI kg/m2)
23.0–24.9 108 (10.7) 94 (9.0) 202 (9.8)
25.0–29.9 93 (9.2) 114 (10.9) 207 (10.1)
³ 30 32 (3.2) 35 (3.4) 67 (3.3)
Waist (cm) 74.4 ± 12.1 70.0 ± 10.4* 72.2 ± 11.5
Waist size (cm)
70–79 284 (28.1) 281 (27.0) 565 (27.5)
80–89 153 (15.2) 102 (9.8) 255 (12.4)
90–99 79 (7.8) 45 (4.3) 124 (6.0)
³ 100 45 (4.5) 16 (1.5) 61 (3.0)
Waist:hip ratio 0.83 ± 0.06 0.77 ± 0.07* 0.80 ± 0.07
Waist:hip ratio
0.70–0.799 289 (28.6) 581 (55.6) 870 (42.4)
0.80–0.899 567 (56.2) 295 (28.3) 862 (42.0)
0.90–0.999 130 (12.9) 39 (3.7) 169 (8.2)
³ 1.00 21 (2.1) 3 (0.3) 24 (1.2)
Systolic BP (mm Hg) 115.9 ± 10.9 111.3 ± 10.7* 113.6 ± 11.0
Diastolic BP (mm Hg) 74.9 ± 8.2 73.2 ± 7.7* 74.0 ± 8.0
Hypertension (³ 140/90 or known) 57 (5.6) 32 (3.1)* 89 (4.3)
Fasting glucose (mg/dl) 89.9 ± 13.9 88.3 ± 10.9* 89.1 ± 12.5
Glucose fasting (mg/dl)
90–99 370 (36.7) 379 (36.4) 49 (36.5)
100–109 119 (11.8) 81 (7.8) 200 (9.8)
110–125 16 (1.6) 4 (0.4) 20 (1.0)
Diabetes (>125 mg/dl or known) 10 (1.0) 4 (0.4) 14 (0.7)
Cholesterol (mg/dl) 153.5 ± 37.6 162.7 ± 29.7* 158.7 ± 49.7
LDL cholesterol (mg/dl) 87.1 ± 34.7 93.2 ± 30.3* 90.2 ± 32.7
High LDL cholesterol (mg/dl)
100–129 214 (21.2) 297 (28.5) 511 (24.9)
130–159 56 (5.6) 62 (6.0) 118 (5.7)
³ 160 38 (3.8) 30 (2.9) 68 (3.3)
Triglycerides (mg/dl) 102.0 ± 58.2 97.4 ± 40.3** 99.7 ± 50.0
High triglycerides (mg/dl)
150–199 58 (5.7) 40 (3.8) 98 (4.8)
200–399 35 (3.5) 22 (2.1) 57 (2.8)
³ 400 5 (0.5) 1 (0.1) 6 (0.3)
HDL cholesterol (mg/dl) 46.1 ± 7.85 49.9 ± 9.79* 48.05 ± 9.09
Low HDL cholesterol (males < 40 mg/dl and females < 50 mg/dl) 163 (16.2) 518 (49.7)* 681 (33.2)
Total: HDL cholesterol 3.48 ± 1.37 3.43 ± 1.18 3.45 ± 1.27
High total: HDL cholesterolcratio ³ 4.5 144 (14.3) 132 (12.7) 276 (13.5)
*: p < 0.01; **: p < 0.05. Values are expressed as Mean ± SD or numbers with percent in parentheses.BMC Cardiovascular Disorders 2009, 9:28 http://www.biomedcentral.com/1471-2261/9/28
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obtained after an overnight fast for estimation of glucose,
total cholesterol, high density lipoprotein (HDL) choles-
terol and triglycerides using previously reported method-
ologies [24,25]. Similar equipment and diagnostic
reagents were used at both the centres to achieve standard-
ization in biochemical measurements. Low density lipo-
protein (LDL) cholesterol was calculated using
Freidewald's formula.
Definitions
Cardiovascular risk factors studied were: smoking, obes-
ity, high waist circumference (WC), hypertension, glucose
intolerance, dyslipidemia (high LDL cholesterol, hyper-
triglyceridemia, low HDL cholesterol or high total-HDL
cholesterol ratio). Overweight or obesity was defined as
body mass index (BMI) ³ 25 kg/m2. Among the measures
of abdominal obesity, high WC was defined as >90 cm in
males and >80 cm in females and high waist:hip ratio
(WHR) was defined as >0.9 in males and >0.8 in females.
Hypertension was defined as a persistent elevation of
blood pressure ³140/³90 mm Hg or use of any anti-
hypertensive medication. Impaired fasting glucose (IFG)
was defined as fasting blood glucose value of ³ 100 mg/dl
and £ 125 mg/dl, and diabetes was defined as fasting blood
glucose value ³126 mg/dl or on any treatment. Dyslipi-
demias were defined according to the USA National Cho-
lesterol Education Program (NCEP) criteria (high LDL
cholesterol as ³ 130 mg%, hypertyriglyceridemia as ³ 150
mg/dl and low HDL cholesterol as <40 mg/dl in males
and <50 mg/dl in females) [26]. High total cholesterol:
HDL ratio was defined as >4.5. Metabolic syndrome was
defined according to the NCEP definition with modified
WC cut off values (males > 90 cm, females > 80 cm) [27].
Statistical analysis
For the purpose of analysis both the data sets were com-
bined into one. Approximate normality was assessed for
anthropometric and biochemical parameters. SPSS 10.0
and STATA 9.0 statistical softwares were used for data
analyses. Quantitative characteristics were summarized by
arithmetic mean and standard deviation. The differences
in the anthropometric and biochemical parameters were
compared using Z-test. Age-specific mean values of vari-
ous anthropometric and biochemical characteristics were
Table 2: Cardiovascular Risk Factors at Different Age-Groups (Mean ± SD) and Trends
Variables Males Females
15–19 years 
(n = 699)
20–29 years 
(n = 175)
30–39 years 
(n = 133)
Regression 
coefficient, 
standardized 
beta, p-value
15–19 years 
(n = 591)
20–29 years 
(n = 311)
30–39 years 
(n = 140)
Regression 
coefficient, 
standardized 
beta, p-value
Body mass 
index (kg/m2)
19.7 ± 3.3 21.5 ± 4.0 24.1 ± 5.6 2.11 ± 
0.17,0.37, 
<0.001
20.0 ± 3.2 20.2 ± 3.3 24.7 ± 5.1 1.80 ± 0.16, 
0.332, <0.001
Waist 
circumference 
(cm)
70.6 ± 9.2 77.7 ± 10.8 89.6 ± 14.0 9.04 ± 0.45, 
0.53, <0.001
66.8 ± 7.7 69.9 ± 9.1 83.8 ± 11.8 7.12 ± 0.39, 
0.491, <0.001
Waist-hip ratio 0.81 ± 0.05 0.85 ± 0.09 0.91 ± 0.07 0.047 ± 0.03, 
0.48, <0.001
0.75 ± 0.06 0.78 ± 0.06 0.84 ± 0.07 0.04 ± 0.01, 
0.457, <0.001
Systolic blood 
pressure 
(mm Hg)
115.0 ± 9.6 118.2 ± 10.8 117.3 ± 15.9 1.56 ± 0.48, 
0.10, 0.001
111.0 ± 9.0 110.4 ± 9.5 114.5 ± 17.0 1.16 ± 0.46, 
0.078, 0.011
Diastolic blood 
pressure 
(mm Hg)
74.4 ± 7.2 75.6 ± 8.2 76.5 ± 11.9 1.07 ± 0.36, 
0.09, 0.003
72.9 ± 6.9 72.8 7.2 75.0 ± 11.2 0.74 ± 0.33, 
0.069, 0.025
Glucose fasting 
(mg/dl)
90.0 ± 9.2 86.7 ± 2.5 94.1 ± 28.2 1.02 ± 0.61, 
0.05, 0.096
88.7 ± 8.3 87.7 ± 8.3 88.4 ± 21.0 -0.36 ± 0.47, -
0.024, 0.441
Total 
cholesterol 
(mg/dl)
144.4 ± 26.0 151.9 ± 38.9 203.9 ± 47.6 25.51 ± 1.5, 
0.48, <0.001
156.4 ± 23.0 160.9 25.7 193.0 ± 41.0 14.81 ± 1.19, 
0.361, <0.001
LDL 
cholesterol 
(mg/dl)
79.0 ± 25.9 86.8 ± 2.5 130.0 ± 40.9 22.11 ± 1.4, 
0.45, <0.001
86.5 ± 24.3 90.9 ± 26.7 126.6 ± 38.0 16.14 ± 1.21, 
0.382, <0.001
Triglycerides 
(mg/dl)
87.5 ± 30.1 104.3 ± 39.9 173.5 ± 111.5 37.99 ± 2.3, 
0.47, <0.001
92.7 ± 28.0 88.2 ± 29.5 137.3 ± 70.6 15.54 ± 1.67, 
0.277, <0.001
HDL 
cholesterol 
(mg/dl)
47.7 ± 6.8 45.1 ± 7.9 39.2 ± 9.0 -3.94 ± 0.32, -
0.36, <0.001
51.1 ± 8.6 52.6 ± 6.2 39.0 ± 8.5 -4.14 ± 0.40, -
0.303, <0.001
Total: HDL 
cholesterol 
ratio
3.1 ± 0.70 3.5 ± 1.4 5.5 ± 2.1 1.06 ± 0.05, 
0.55, <0.001
3.2 ± 0.73 3.2 ± 0.85 5.2 ± 1.72 0.77 ± 0.045, 
0.468, <0.001BMC Cardiovascular Disorders 2009, 9:28 http://www.biomedcentral.com/1471-2261/9/28
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compared using one way ANOVA followed by post-hoc
Bonferroni test. Anthropometric and biochemical charac-
teristics were further categorized according to the cut off
values as mentioned in the definition section. Categorical
variables were summarized by percentages. Numerical
trends in various cardiovascular risk factors across differ-
ent age groups were assessed using regression analyses
using CURVEFIT command of SPSS (version 10.0).
Regression coefficients (B), standard deviations, standard-
ized regression coefficients (beta), and p values were esti-
mated. C2 test for trend for performed for ordinal variables
using the SPSS and are reported with p values. To deter-
mine the age associated escalation of risk factors odds
ratios were calculated using logistic regression analysis.
Univariate odds ratios (OR) and 95% confidence intervals
(CI) were calculated with age-group 15–19 as baseline
and compared with age-group 20–29 and 30–39 years. To
determine significance of different measures of obesity
(BMI, WC, WHR) multivariate logistic regression analyses
were performed after adjustment for these factors. P value
< 0.05 was considered statistically significant.
Results
Data of 2051 subjects aged 15–39 years (males 1009,
females 1042) were evaluated in the present study. Sub-
jects in different age groups were: 15–19 years 1292
(63.0%, 701 males and 591 females), 20–29 years 721
(20.5%, 174 males and 281 females), and 30–39 years
270 (6.0%, 59 males and 65 females). The prevalence of
smoking was 6.6%, being higher in males (11.8%) than in
females (1.4%). Various physical and biochemical charac-
teristics of the study population are presented in Table 1.
Mean BMI was similar in both males and females while
WC, WHR and systolic and diastolic blood pressures were
significantly higher in males as compared to females (p <
0.01). Mean fasting blood glucose was higher in males as
compared to females (p < 0.01). The mean levels of total
cholesterol, HDL cholesterol and LDL cholesterol were
significantly higher in females (p < 0.01) whereas triglyc-
erides levels were higher in males (p < 0.05). Obesity
(BMI ³ 25 kg/m2) was present in 13.4% (males 12.4%,
females 14.3%), high WC in 13.3% (males 11.9%,
females 14.7%), high WHR in 21.2% (males 13.7%,
females 28.4%) and hypertension in 4.3% (males 5.6%,
females 3.1%) subjects. Diabetes (known or diagnosed)
was present in very small proportion (0.7%) of subjects,
but impaired fasting glucose (100–125 mg/dl) was
present in 10.8% (13.4% males, 8.2% females). Among
the dyslipidemias, hypercholesterolemia was present in
7.9% (8% males, 7.8% females), high LDL cholesterol (³
130 mg/dl) in 9% (9.2% males, 8.7% females), hypertrig-
lyceridemia in 7.9% (9.7% males, 6% females), low HDL
Table 3: Prevalence of Various Cardiovascular Risk Factors at Different Age-Groups and Trends
Variables Males Females
15–19 years 
(n = 699)
20–29 years 
(n = 175)
30–39 years 
(n = 133)
X2 for trend 
(p-value)
15–19 years 
(n = 591)
20–29 years 
(n = 311)
30–39 years 
(n = 140)
X2 for trend 
(p-value)
Body mass index 
³ 25 Kg/m2
53 (7.6) 20 (11.5) 49 (36.8) 89.85 (<0.001) 52 (8.8) 23 (7.4) 73 (52.1) 191.09 
(<0.001)
Body mass index 
³ 30 Kg/m2
7 (1.0) 7 (4.0) 17 (12.8) 52.55 (<0.001) 5 (0.8) 7 (2.3) 22 (15.7) 80.62 (<0.001)
Waist circumference 
> 90 cm/80 cm
32 (4.6) 20 (11.4) 67 (50.4) 224.94 
(<0.001)
36 (6.1) 31 (10.0) 86 (61.4) 284.55 
(<0.001)
Waist hip ratio 
> 0.9/0.8
34 (4.9) 33 (18.9) 69 (51.9) 216.64 
(<0.001)
85 (14.4) 107 (34.4) 104 (74.3) 207.56 
(<0.001)
Hypertension 16 (2.3) 10 (5.7) 31 (23.3) 92.45 (<0.001) 2 (0.3) 5 (1.6) 25 (17.9) 119.89 
(<0.001)
Impaired fasting 
glucose 
(100–125 mg/dl)
99 (14.2) 10 (5.7) 26 (19.5) 13.59 (0.001) 49 (8.3) 20 (6.4) 16 (11.4) 3.25 (0.197)
Diabetes mellitus 
(³ 126 mg/dl)
- 1 (0.6) 9 (6.8) 52.43 (<0.001) - - 4 (2.9) 25.87 (<0.001)
LDL cholesterol 
³ 130 mg/dl
17 (2.4) 24 (13.7) 54 (40.6) 195.08 
(<0.001)
19 (3.2) 18 (5.8) 55 (39.3) 188.05 
(<0.001)
Triglycerides ³ 150 
mg/dl
21 (3.0) 18 (10.3) 57 (42.9) 205.92 
(<0.001)
19 (3.2) 9 (2.9) 35 (25.0) 102.32 
(<0.001)
HDL cholesterol <40 
mg/dl
56 (8.0) 30 (17.1) 77 (57.9) 205.09 
(<0.001)
268 (45.3) 120 (38.6) 129 (92.1) 120.73 
(<0.001)
Total: HDL 
cholesterol ratio 
³ 4.5
26 (3.7) 30 (17.1) 79 (59.4) 300.95 
(<0.001)
28 (4.7) 22 (7.1) 82 (58.6) 309.04 
(<0.001)
Metabolic syndrome - 9 (5.1) 26 (19.5) 129.04 
(<0.001)
1 (0.2) 3 (1.0) 28 (20.0) 156.14 
(<0.001)
Numbers in parentheses are percent.BMC Cardiovascular Disorders 2009, 9:28 http://www.biomedcentral.com/1471-2261/9/28
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cholesterol in 33.2% (16.2% males, 49.7% females) and
high total:HDL cholesterol ratio in 13.5% (14.3% males,
12.7% females) subjects (Table 1).
Age-specific mean values of various clinical, anthropo-
metric and biochemical characteristics are shown in Table
2. Both in males and females significantly increasing trend
in BMI, WC, WHR, systolic BP, cholesterol, LDL choles-
terol, triglycerides and a decreasing trend in HDL choles-
terol levels is observed (regression analyses, p < 0.001). In
both males and females there is a steep increase in mean
BMI, WC, and WHR as these men move from age-groups
20–29 to 30–39 years. Similar increasing trends are
observed in mean levels of total- and LDL cholesterol and
triglycerides with declining trends in HDL cholesterol lev-
els (Figure 1, p < 0.001). Age-related trends in the preva-
lence of various cardiovascular risk factors are presented
in Table 3. In both men and women the prevalence of
obesity is low in age groups 15–20 and 20–29 years with
a steep increase in age-group 30–39 years (men 36.8%,
women 52.1%) (C2 test, p for trend < 0.001). Similar
changes are observed in the prevalence of high WC and
high WHR (p for trend < 0.001). A significantly increasing
trend in prevalence of hypertension, impaired fasting glu-
cose, high LDL cholesterol, hypertriglyceridemia, high
total:HDL cholesterol ratio, low HDL cholesterol, diabe-
tes and the metabolic syndrome is also observed.
Regression analyses reveal that age is an important deter-
minant of blood pressure as well as multiple biochemical
factors (Table 4). BMI, WC as well as WHR are signifi-
cantly positively related with systolic BP, total cholesterol,
LDL cholesterol, and triglycerides and negatively with
HDL cholesterol. Age-adjustment reveals that while BMI is
a more important determinant of systolic BP, waist cir-
cumference and waist-hip ratio are more important for
biochemical abnormalities. All the associations loose sig-
nificance when adjusted for age, BMI and measures of
truncal obesity (Table 4). Trends of risk factors change
with age using univariate and multivariate odds ratios are
shown in Table 5. At age 15–19 years the prevalence (%)
of risk factors in males and females, respectively, was over-
weight/obesity in 7.6, 8.8; high WHR 4.9, 14.4; hyperten-
sion 2.3, 0.3; high LDL cholesterol 2.4, 3.2; high
Trends of increase in prevalence of hypertension, high LDL  cholesterol, high triglyceride (TG) levels, low HDL choles- terol and diabetes with age in males and females Figure 2
Trends of increase in prevalence of hypertension, 
high LDL cholesterol, high triglyceride (TG) levels, 
low HDL cholesterol and diabetes with age in males 
and females. Relative prevalence of risk factors at age-
groups 15–19 (odds ratio = 1), 20–29 and 30–39 is shown. 
The increase is slow from age 15–19 to 20–29 years with an 
exponential increase at age-group 30–39 years (p < 0.001).
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Age-related escalation in mean levels of systolic BP, fasting  glucose, total cholesterol, LDL cholesterol and triglycerides  and decline in HDL cholesterol levels in males and females (p  for trend < 0.01) Figure 1
Age-related escalation in mean levels of systolic BP, 
fasting glucose, total cholesterol, LDL cholesterol 
and triglycerides and decline in HDL cholesterol lev-
els in males and females (p for trend < 0.01). Values of 
systolic BP are in mm Hg and the others in mg/dl. Bars and 
whiskers indicate mean and SEM values respectively.
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triglycerides 3.0, 3.2; low HDL cholesterol 8.0, 45.3; high
total:HDL ratio 3.7, 4.7, diabetes 0.0 and metabolic syn-
drome in 0.0, 0.2 percent. In males and females, respec-
tively, as compared to age group 15–19 years, ORs for risk
factors at age groups 20–29 years are for smoking 5.3, 1.0;
obesity 1.6, 0.8; truncal obesity 4.5, 3.1; hypertension 2.6,
4.8; high LDL cholesterol 6.4, 1.8; high triglycerides 3.7,
0.9; low HDL cholesterol 2.4, 0.8; high total:HDL choles-
terol 1.6, 1.0; diabetes 4.0, 1.0; and the metabolic syn-
drome 37.7, 5.7 (Table 5). The escalation is highly
significant at age 30–39 with ORs for smoking 16.0, 6.3;
overweight 7.1, 11.3; truncal obesity 21.1, 17.2; hyperten-
sion 13.0, 64.0; high LDL cholesterol 27.4, 19.5; high trig-
lycerides 24.2, 10.0; low HDL cholesterol 15.8, 14.1; high
total:HDL cholesterol 37.9, 6.10; diabetes 50.7, 17.4; and
metabolic syndrome 168.5, 146.2 (Figure 2, p < 0.01 for
all parameters). Multivariate adjustment for BMI, waist
size and WHR in men and women aged 30–39 years
results in attenuation in ORs for hypertension and various
lipid parameters but remain significant.
Discussion
This study shows a low prevalence of multiple cardiovas-
cular risk factors (smoking, hypertension, lipid abnormal-
ities and diabetes) among adolescents in an Indian urban
population. The prevalence of multiple risk factors
increases at age-group 20–29 years with an exponential
increase in age group 30–39 years. Increasing risk factors
correlate with body mass index, waist circumference and
waist-hip ratio. A rapid increase in risk factors in young
adulthood identifies the target group for interventions.
Wardle et al reported development of adiposity during
adolescence in an ethnically and socioeconomically
diverse sample of young people in Britain [28]. It was
observed that prevalence of overweight and obesity was
high in London school students and there were significant
socioeconomic and ethnic inequalities with low socioeco-
nomic status Blacks having the highest prevalence. It was
concluded that overweight and obesity was well estab-
lished by the age of 11 years and prevention efforts need
to be targeted early. Obesity among children that tracks
into adulthood has also been reported in studies from
Europe and USA [5-16]. Gordon-Larsen et al studied five
year obesity incidence in the transition period between
adolescence and adulthood as part of US National Longi-
tudinal Study of Adolescent Health [29]. It was observed
that during the 5-yer transition period the obesity inci-
dence was 12.7% and there was a significant increase in
obesity from 10.9% at 18 years of age to 22.1% at young
adulthood. Our study on the other hand shows that the
transition using similar obesity definitions occurs slightly
later than the western populations. Reddy et al studied
industrial populations in different parts of India and
reported risk factor trends from age groups 20–29 years to
³60 years [30]. In both men and women there was a steep
increase in overweight and central obesity at age-group
30–39 years associated with increase in hypertension and
Table 4: Standardized Regression Coefficients for Association of Cardiovascular Risk Factors with Age and Different Measures of 
Obesity.
Age Body Mass Index Waist Circumference Waist Hip Ratio
Univariate Age-
Adjusted
Multivariate 
adjusted for 
age, waist, 
WHR
Univariate Age-
Adjusted
Multivariate 
adjusted for 
age, body 
mass index, 
WHR
Univariate Age-
Adjusted
Multivariate 
adjusted for 
age, body 
mass index, 
waist
Age - 0.394*** - - 0.536*** - - 0.417*** - -
Systolic BP 0.092*** 0.311*** 0.375*** 0.145*** 0.335*** 0.402*** 0.207*** 0.261*** 0.269*** 0.099**
Cholesterol 0.468*** 0.283*** 0.117*** -0.012 0.340*** 0.125*** 0.236*** 0.192*** -0.004 -0.142***
LDL 
cholesterol
0.459*** 0.276*** 0.113*** -0.018 0.341*** 0.133*** 0.227*** 0.208*** 0.020 -0.111***
HDL 
cholesterol
-0.337*** -0.195*** -0.073** 0.094* -0.302*** -0.171*** -0.202*** -0.275*** -0.163*** -0.069*
Triglycerides 0.414*** 0.246*** 0.098*** -0.028 0.325*** 0.144*** 0.183** 0.240*** 0.081* -0.021
Glucose 
Fasting
0.038 0.026 0.013 -0.073 0.056* 0.049 0.127* 0.044* 0.034 -0.020
BP blood pressure; WHR waist hip ratio; * p < 0.01; ** p < 0.001; ** p < 0.001;B
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Table 5: Relative prevalence of various risk factors with increasing age in males and females presented as univariate and adjusted odds ratios and 95% confidence intervals
Variables Age group Univariate odds ratios Adjusted for body mass index Adjusted for waist 
circumference
Adjusted for waist hip ratio
Males
Smoking 15–19 1.0 1.0 1.0 1.0
20–29 5.3 (3.6–7.0) -- -- --
30–39 16.0 (10.5–21.5) -- -- --
Body mass index ³ 25 kg/m2 15–19 1.0 -- 1.0 1.0
20–29 1.6 (0.9–2.7) -- -- --
30–39 7.1 (4.5–11.2) -- -- --
Waist:hip ratio > 0.9 15–19 1.0 1.0 -- --
20–29 4.5 (2.7–7.6) -- -- --
30–39 21.1 (12.9–34.2) -- -- --
Hypertension 15–19 1.0 1.0 1.0 1.0
20–29 2.6 (1.2–5.8) 1.7 (0.7–3.9) 1.1 (0.4–2.8) 1.3 (0.5–3.2)
30–39 13.0 (6.9–24.6) 7.4 (3.7–14.8) 3.4 (1.5–7.5) 4.3 (1.9–9.5)
LDL cholesterol ³ 130 mg/dl 15–19 1.0 1.0 1.0 1.0
20–29 6.4 (3.3–12.2) 5.9 (3.0–11.5) 4.7 (2.4–9.4) 5.4 (2.7–10.9)
30–39 27.4 (15.2–49.6) 22.2 (11.7–42.0) 16.7 (8.2–34.1) 20.1 (9.8–41.3)
Triglycerides ³ 150 mg/dl 15–19 1.0 1.0 1.0 1.0
20–29 3.7 (1.9–7.1) 2.7 (1.4–5.4) 2.4 (1.2–4.8) 2.6 (1.3–5.1)
30–39 24.2 (13.9–42.1) 19.9 (10.9–36.1) 15.8 (8.2–30.8) 16.8 (8.6–32.6)
HDL cholesterol < 40 mg/dl 15–19 1.0 1.0 1.0 1.0B
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20–29 2.4 (1.5–3.8) 2.4 (1.5–3.9) 1.9 (1.2–3.3) 1.7 (1.0–2.9)
30–39 15.8 (10.2–24.5) 15.1 (9.3–24.7) 12.9 (7.4–22.6) 10.9 (6.4–18.9)
Total: HDL cholesterol > 4.5 15–19 1.0 1.0 1.0 1.0
20–29 1.6 (1.4–1.9) 1.5 (1.3–1.8) 1.4 (1.1–1.7) 1.4 (1.2–1.7)
30–39 37.9 (22.5–63.9) 32.7 (18.6–57.5) 27.9 (14.8–52.4) 26.8 (14.3–50.3)
Diabetes 15–19 1.0 1.0 1.0 1.0
20–29 4.0 (0.3–64.5) 4.2 (0.3–69.9) 2.6 (1.0–72.3) 2.4 (0.9–67.0)
30–39 50.7 (6.4–403.4) 27.8 (3.2–242.7) 26.2 (1.9–365.8) 19.9 (1.2–336.1)
Metabolic syndrome 15–19 1.0 1.0 1.0 1.0
20–29 37.7 (4.8–298.2) 20.7 (2.5–171.7) 14.3 (1.6–128.4) 17.3 (2.1–148.5)
30–39 168.5 (22.8–1247.1) 95.6 (12.3–741.5) 62.9 (6.4–621.3) 59.1 (6.2–568.1)
Females
Smoking 15–19 1.0 1.0 1.0 1.0
20–29 1.0 -- -- --
30–39 6.3 (5.5–7.1) -- -- --
Body mass index ³ 25 kg/m2 15–19 1.0 1.0 1.0 1.0
20–29 0.8 (0.5–1.4) -- -- --
30–39 11.3 (7.3–11.5) -- -- --
Waist:hip ratio > 0.8 15–19 1.0 1.0 1.0 1.0
20–29 3.1 (2.2–4.3) -- -- --
30–39 17.2 (11.0–26.8) -- -- --
Hypertension 15–19 1.0 1.0 1.0 1.0
Table 5: Relative prevalence of various risk factors with increasing age in males and females presented as univariate and adjusted odds ratios and 95% confidence intervals B
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20–29 4.8 (0.9–24.9) 4.5 (0.9–23.7) 3.1 (0.6–16.6) 3.2 (0.6–16.7)
30–39 64.0 (14.9–73.9) 18.2 (4.1–82.9) 10.3 (2.0–52.0) 39.1 (7.9–192.7
LDL cholesterol ³ 130 mg/dl 15–19 1.0 1.0 1.0 1.0
20–29 1.8 (0.9–3.6) 1.8 (0.9–3.5) 1.6 (0.8–3.2) 1.9 (0.9–3.7)
30–39 19.5 (11.0–34.4) 18.2 (9.5–34.8) 17.2 (8.1–36.7) 19.5 (9.7–39.2)
Triglycerides ³ 150 mg/dl 15–19 1.0 1.0 1.0 1.0
20–29 0.9 (0.4–2.0) 0.9 (0.4–2.0) 0.8 (0.3–1.8) 0.8 (0.4–1.9)
30–39 10.0 (5.5–18.2) 8.5 (4.3–16.6) 7.0 (3.2–15.1) 8.2 (4.0–16.8)
HDL cholesterol < 40 mg/dl 15–19 1.0 1.0 1.0 1.0
20–29 0.8 (0.6–1.0) 0.8 (0.6–1.0) 0.7 (0.5–0.9) 0.7 (0.6–1.1)
30–39 14.1 (7.5–26.7) 11.9 (6.1–23.2) 10.6 (5.2–21.8) 15.8 (7.8–32.0)
Total: HDL cholesterol > 4.5 15–19 1.0 1.0 1.0 1.0
20–29 1.0 (0.9–1.2) 1.0 (0.8–1.2) 0.9 (0.8–1.1) 0.9 (0.8–1.2)
30–39 6.1 (4.5–8.2) 5.9 (4.3–8.3) 5.3 (3.7–7.6) 5.8 (4.1–8.1)
Diabetes 15–19 1.0 1.0 1.0 1.0
20–29 1.0 1.0 1.0 1.0
30–39 17.4 (1.9–156.5) 17.0 (1.3–217.7) 31.6 (0.6–1605.0) 22.0 (1.0–474.5)
Metabolic syndrome 15–19 1.0 1.0 1.0 1.0
20–29 5.7 (0.6–55.3) 5.2 (0.5–51.1) 2.2 (0.2–23.4) 3.0 (0.3–31.0)
30–39 146.2 (19.9–1027.9) 75.1 (9.7–583.9) 19.7 (2.5–155.3) 48.8 (6.3–378.9)
Table 5: Relative prevalence of various risk factors with increasing age in males and females presented as univariate and adjusted odds ratios and 95% confidence intervals BMC Cardiovascular Disorders 2009, 9:28 http://www.biomedcentral.com/1471-2261/9/28
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biochemical risk factors. Reasons for the increase in
weight beyond 30 years of age could be multiple. Socioe-
conomic changes that occur at this age in men include
financial independence, marriage, transition from an
active to sedentary working lifestyle, dietary changes, and
psychological changes related to material and social envi-
ronment [31]. In predominantly home-bound women
apart from these changes others include less physical
activity with grown-up children, dietary indiscretion and
changes material environment [32,33]. We did not study
these socioeconomic variables in the present study and
hence cannot comment on their importance. Studies in
emigrant South Asians to UK have reported similar risk
factor trends [34] as in the present study and highlight
importance of lifestyle in escalating cardiovascular risks.
The INTERHEART study reported that multiple cardiovas-
cular risks occurred at a younger age among South Asians
which explained younger age of acute myocardial infarc-
tion in these subjects [35]. The present study also shows a
younger age of escalation of multiple cardiovascular risk
factors and is similar to these studies.
Obesity is a proximate factor for increase in multiple met-
abolic abnormalities [36]. The present study also shows
that development of obesity and central obesity is associ-
ated with simultaneous increase in many biological risk
factors such as changes in blood pressure levels and glu-
cose and lipid abnormalities. Similar findings have been
reported from the Bogalusa Heart Study [6], NHANES [7],
and CARDIA study [9] and many other North American
and European studies [5]. The present study shows that
the increase in risk factors in a North Indian urban popu-
lation starts at about the age of 30 years and focus of pre-
vention should be at subjects lower than this age.
Several limitations of the present study have to be high-
lighted. The sample survey for the adults was a population
based data collection while for adolescents a school-based
survey was performed. This would have excluded the very
poor and illiterate children from the study in children in
spite of inclusion of illiterates in the adult groups. There is
a steep increase in BMI in the age groups ³30 years in both
men and women and inclusion of more poor children
with low BMI would have enhanced the already steep
change in BMI with increasing age. Secondly, the sample
size at different age-groups is not similar and this could
have resulted in a bias. However, this is a limitation of
population-based study and can be overcome by using
purposive age-stratified sampling which was not the
design of the present study. Thirdly, this is analysis of
cross-sectional data while an ideal study to observe age-
related tracking of risk factors involves a prospective
design [37]. Prospective studies are expensive and time-
consuming and cross-sectional studies such as this are
hypothesis generating and most of the time similar con-
clusions are reached. Fourthly, we used adult BMI criteria
for defining overweight and obesity in subjects less than
18 years of age although the criteria are applicable to
adults only. However, criteria of >95th percentile for obes-
ity in adolescents are widely debated [29] and for sake of
comparability our approach is justified. And finally, mul-
tiple ways to analyze secular data are available often
involving complex statistics. As the present study was
cross-sectional in nature we did not use such analyses.
Conclusion
India and many developing countries suffer from the dou-
ble burden of under nutrition and over nutrition [38].
There is an urgent need to improve maternal and child-
hood nutrition to prevent fetal and childhood stunting
and malnutrition related diseases. On the other hand,
there is sufficient evidence that problems of under nutri-
tion have been replaced by over nutrition in urban adults
in these countries [39]. The crucial issue is age at which
screening and intervention strategies should be initiated
[40]. The present study shows that dietary and lifestyle
changes to prevent adiposity and obesity and consequent
epidemic of cardiovascular diseases in India and other
such countries can be prevented by targeting men and
women at age of about 30 years. A multi-factorial risk
screening and intervention approach [41] at the popula-
tion level could provide immediate benefit.
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